Reinhard Kandera's most recent trade in Hookipa Pharma Inc was a trade of 406,200 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 15, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hookipa Pharma Inc | Reinhard Kandera | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2024 | 406,200 | 406,200 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Reinhard Kandera | Director, Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.72 per share. | 21 Aug 2023 | 7,000 | 43,092 (0%) | 0% | 0.7 | 5,075 | Common Stock |
| Hookipa Pharma Inc | Reinhard Kandera | Director, Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.71 per share. | 16 Aug 2023 | 8,000 | 36,092 (0%) | 0% | 0.7 | 5,712 | Common Stock |
| Hookipa Pharma Inc | Reinhard Kandera | Director, Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.88 per share. | 30 Jun 2023 | 12,000 | 28,092 (0%) | 0% | 0.9 | 10,560 | Common Stock |
| Hookipa Pharma Inc | Reinhard Kandera | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 214,800 | 214,800 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Reinhard Kandera | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 92,950 | 92,950 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Reinhard Kandera | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2022 | 92,950 | 92,950 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Reinhard Kandera | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 23,427 | 23,427 | - | - | Stock Option (Right to Buy) | |
| Hookipa Pharma Inc | Reinhard Kandera | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 3.00 per share. | 01 Feb 2022 | 14,056 | 16,092 (0%) | 0% | 3 | 42,168 | Common Stock |
| Hookipa Pharma Inc | Reinhard Kandera | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2021 | 69,300 | 69,300 | - | - | Stock Option (Right to Buy) |